See if you qualify!
We are currently recruiting for a depression research trial. All participants enrolled in this depression study will first receive an FDA-approved antidepressant for a period of six weeks. Then, if eligible, the participants will enter a second period of 6 weeks of treatment and either continue to receive the FDA-approved antidepressant or be switched to an investigational drug during one of the visits of the second period.
Key Entry Criteria:
Male or female between 18 and 65 years of age
BMI of ≥18 and ≤40 kg/m2
Current or recent treatment of depression with a pharmacologic agent
Negative urine drug screen
Willing to comply with study protocol and visit schedule
Please complete the form below, and a member of our study team will reach out to you.